Story
GSK Shares Rise on Strong Q2 Earnings, Reaffirmed 2026 Guidance
Summary
GSK stock gained after the biopharmaceutical company reported second-quarter revenue and profit that surpassed analyst expectations, driven by strong growth in its vaccines and specialty medicines divisions.
Shares of GSK (GSK) surged in pre-market trading after the British pharmaceutical company announced second-quarter 2026 financial results that beat market expectations and reaffirmed its full-year guidance.
Second-Quarter Performance Exceeds Forecasts
GSK reported total sales of £8.4 billion for the second quarter, a 5% increase year-over-year on a constant exchange rate basis. This figure notably surpassed the analyst consensus estimate of $8.25 billion. The company's core earnings per share rose by 9% to 50.5p, while core operating profit increased by 7% to £2.8 billion.
The robust top-line growth was fueled by strong performance in two key segments:
- Specialty Medicines: Sales grew 14% to £3.8 billion.
- Vaccines: Sales increased by 8% to £2.3 billion.
Strategic Outlook and Reaffirmed Guidance
AdCoinciding with the earnings release, GSK hosted an investor event where CEO Luke Miels outlined a long-term strategy to exceed £40 billion in annual sales by 2031. The company also provided updates on its drug pipeline following its acquisition of Nuvalent.
For the full year 2026, GSK reaffirmed its guidance for turnover growth of 3–5% and core operating profit growth of 7–9%, both at constant exchange rates. This confirmation provided investors with additional confidence in the company's operational momentum.
Market Reaction
The stock jumped 3.3% in pre-open trading on the news. The rally was distinctly company-specific, occurring against a backdrop of a mixed and cautious broader market. The positive results were particularly impactful as some analysts had maintained a cautious outlook on the company ahead of the report, citing strategic shifts in its oncology investments.
Read next
More on Stocks
Divergence in China: Consumer Stocks Hit Decade Low as Capital Flows to AI
Chinese consumer-focused stocks have fallen to their lowest levels in nearly ten years, pressured by weak domestic spending and a significant shift in investor capital toward the booming artificial intelligence sector.
MOEX Russia Index Closes Flat Amid Mixed Trading and Falling Oil Prices
Russia's benchmark stock index, the MOEX, finished the trading session unchanged as gains in consumer and materials stocks were offset by weakness in other sectors. The flat close came despite a drop in global oil prices and a strengthening of the Russian ruble.
Boeing 737 MAX Software Glitch Affects Autopilot, Prompts FAA Review
Boeing has identified a software flaw in its 737 MAX jets that can disable some automated navigation functions during certain landing scenarios, according to a Wall Street Journal report. The issue has prompted an FAA investigation and requests from major U.S. airlines to halt deliveries of aircraft with the new software.
Trump Announces New Fuel Economy Rules to End Biden-Era EV Push
Former President Donald Trump stated he has approved new fuel economy standards designed to reverse the Biden administration's policies that encouraged electric vehicle production. The move, announced on social media, signals a major shift in U.S. automotive regulatory policy.